XML 26 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022 [1]   4,519,578      
Beginning balance at Dec. 31, 2022 $ 349,881 $ 0 [1] $ 783,047 $ (7,235) $ (425,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of stock awards (in shares) [1]   80,530      
Shares repurchased for withholding tax on stock awards (in shares) [1]   (21,267)      
Shares repurchased for withholding tax on stock awards (271)   (271)    
Stock-based compensation expense 5,075   5,075    
Net loss (64,813)       (64,813)
Foreign currency translation gain (loss) $ 738     738  
Ending balance (in shares) at Dec. 31, 2023 4,578,841 4,578,841 [1]      
Ending balance at Dec. 31, 2023 $ 290,610 $ 0 [1] 787,851 (6,497) (490,744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for vesting of stock awards (in shares) [1]   53,464      
Shares repurchased for withholding tax on stock awards (in shares) [1]   (18,026)      
Shares repurchased for withholding tax on stock awards (142)   (142)    
Stock-based compensation expense 2,385   2,385    
Net loss (66,717)       (66,717)
Foreign currency translation gain (loss) $ (2,414)     (2,414)  
Ending balance (in shares) at Dec. 31, 2024 4,614,279 4,614,279 [1]      
Ending balance at Dec. 31, 2024 $ 223,722 $ 0 [1] $ 790,094 $ (8,911) $ (557,461)
[1]
(1) Common share and par value amounts have been adjusted to give retroactive effect to the 1-for-10 reverse stock split effected on February 12, 2025.